Goldman Sachs Lowers Estimates On CME Group

According to Goldman Sachs, CME Group CME 2Q11 and 2011 estimates were lowered to $4.20/16.50 from $4.40 and $17.00. Goldman Sachs said that there is no fundamental change to its earnings outlook. “Our 2012-2013 EPS estimates remain intact at $18.70 and $20.75, and we make no change to our 12-month price target of $310.” CME Group closed on Friday at $294.50.